fbpx
October 27, 2021

For MS Pain: Focus on Flexibility, Nondrug Treatments For MS Pain: Focus on Flexibility, Nondrug Treatments

Pain is as individual as patients are, a multiple sclerosis (MS) specialist told colleagues, and one size does not fit all when it comes to treatment. […]
October 26, 2021

Which Agent Best for Neuromyelitis Optica? Which Agent Best for Neuromyelitis Optica?

A new indirect comparison of the three new FDA-approved treatment options for adults with aquaporin4+ (AQP4+) neuromyelitis optica spectrum disorder (NMOSD), has suggested that eculizumab is […]
October 26, 2021

Antipsychotic Effective for Steroid-Induced Psychosis in MS Antipsychotic Effective for Steroid-Induced Psychosis in MS

The popular antipsychotic quetiapine (Seroquel) seems to calm patients with multiple sclerosis (MS) who develop psychiatric distress after taking corticosteroids, a new case review says. “Our […]
October 26, 2021

More Evidence Mindfulness Is Effective for Migraine More Evidence Mindfulness Is Effective for Migraine

Although both mindfulness and headache education reduce migraine frequency, only mindfulness significantly improves disability, depression, quality of life, and pain catastrophizing/magnifying pain-related thoughts, new research shows. […]
October 25, 2021

Disability May Accumulate in the Relapsing Phase of MS Disability May Accumulate in the Relapsing Phase of MS

Disability accumulation may occur independently of relapses for some patients in the early phase of relapsing-remitting multiple sclerosis (MS), according to new research. Approximately 61% of […]
October 25, 2021

Motor Imagery Improves MS Motor Imagery Improves MS

Motor imagery (MI) is a useful tool in the management of multiple sclerosis (MS), with the potential to improve balance, walking, and even cognitive function and […]
October 25, 2021

Antihypertensives Tied to Lower Alzheimer’s Pathology Antihypertensives Tied to Lower Alzheimer’s Pathology

Certain antihypertensive medications, particularly diuretics, are linked to lower Alzheimer’s disease neuropathology (ADNP) and other brain disease processes, new research shows. Investigators found that use of […]
October 22, 2021

Dimethyl Fumarate Versus Teriflunomide for Relapsing MS Dimethyl Fumarate Versus Teriflunomide for Relapsing MS

Treatment with dimethyl fumarate, compared with teriflunomide, is associated with better clinical outcomes in patients with relapsing-remitting multiple sclerosis (MS), according to new research. Time to […]
October 21, 2021

Most Families Doubt Docs’ Prognosis in Severe Brain Injury Most Families Doubt Docs’ Prognosis in Severe Brain Injury

Almost two thirds of families of patients with severe acute brain injury either don’t understand, or don’t believe, their physician’s prognosis of the likelihood of full […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0